{'fraction_non_alphanumeric': 0.02834008097165992, 'fraction_numerical': 0.002699055330634278, 'mean_word_length': 5.934579439252336, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Zebrafish with antisense-knockdown of cardiac troponin C as a model of hereditary dilated cardiomyopathy.

unctional abnormalities of cardiac troponin caused by either mutations or auto-antibodies can induce dilated cardiomyopathy (DCM),1,2 which is characterized by left ventricular enlargement and systolic dysfunction resulting from a reduction in the myocardial force of contraction. DCM causes congestive heart failure, which can be treated with diuretics, angiotensin-converting enzyme inhibitors (or angiotensin type-I receptor blockers), β-adrenergic blockers, and most aggressively in unresponsive patients with cardiac transplantation. However, the prognosis of DCM is still poor, so there is a need for new therapeutic approaches.